Remote Active Monitoring in Patients With Heart Failure (RAPID-RF): Design and Rationale

Journal of Cardiac Failure

Volumn 13, Issue 4, 2007, Pages 241-246

  Saxon, Leslie A ^a   Boehmer, John P ^b   Neuman, Stacey ^c   Mullin, Christopher M ^d  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^c BOSTON SCIENTIFIC CORPORATION   (United States)

^d Integra Group   (United States)

Author keywords

cardioverter resynchronization therapy; defibrillator; heart failure; Remote monitoring

Indexed keywords

ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DEFIBRILLATOR; DIAGNOSTIC VALUE; HEART FAILURE; HIGH RISK PATIENT; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PATIENT CARE; PATIENT MONITORING; PRIORITY JOURNAL; RADIOFREQUENCY; RANDOMIZED CONTROLLED TRIAL; REMOTE SENSING; TELEMETRY; TELEPHONE;

ADULT; DATA COLLECTION; DEFIBRILLATORS, IMPLANTABLE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HUMANS; MONITORING, PHYSIOLOGIC; MULTICENTER STUDIES; PATIENT SATISFACTION; PROSPECTIVE STUDIES; QUALITY ASSURANCE, HEALTH CARE; REGISTRIES; REMINDER SYSTEMS; REMOTE CONSULTATION; RESEARCH DESIGN;

EID: 34248633374     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2006.12.004     Document Type: Article

References (22)

1. American Heart Association. Heart disease and stroke statistics-2005 update (2005), American Heart Association, Dallas (Tx)
2. Ho K.K., Pinssky J.L., Kannel W.B., and Levy D. The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol 22 (1993) 6A-13A
3. Croft J.B., Giles W.A., Pollard R.A., Casper M.L., Anda R.F., and Livengood J.R. National trends in the initial hospitalization for heart failure. J Am Geriatr Soc 45 (1997) 270-275
4. Rich M.W. Epidemiology, pathophysiology, and etiology of congestive heart failure in older adults. J Am Geriatr Soc 45 (1997) 968-974
5. Whellan D.J., Hasselblad V., Peterson E., O'Conner C.M., and Schulman K.A. Metaanalysis and review of heart failure disease management randomized controlled clinical trials. Am Heart J 149 (2005) 722-729
6. Cleland J.G., Louis A.A., Rigby A.S., Janssens U., Balk A.H., and TEN-HMS Investigators. Noninvasive home telemonitoring for patients with heart failure at high risk of recurrent admission and death. J Am Coll Cardiol 45 (2005) 1654-1664
7. HFSA 2006 comprehensive heart failure practice guideline. J Card Fail 12 (2006) e1-e122
8. Bristow M.R., Saxon L.A., Boehmer J., et al. Cardiac-Resynchronization Therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350 (2004) 2140-2150
9. Reicin G.M., and Wittes J. Morgan Stanley equity research North American, hospital supplies and medical technology. industry overview-an investors' guide to ICDs. New York: Morgan Stanley. October 8 (2002)
10. Kimmelstiel C., Levine D., Perry K., et al. Randomized, controlled evaluation of short- and long-term benefits of heart failure disease management within a diverse provider network. Circulation 110 (2004) 1450-1455
11. Rich M.W. Heart failure disease management programs: efficacy and limitations. Am J Med 110 (2001) 410-412
12. West J.A., and DeBusk R.F. Disease management systems for chronic cardiovascular diseases: focus on heart failure. Adv Intern Med 46 (2001) 295-306
13. Winters S.L., Packer D.L., Marchlinski F.E., et al. Consensus statement on indications, guidelines for use, and recommendations for follow-up of implantable cardioverter defibrillators. Pacing Clin Electrophysiol 24 (2001) 262-269
14. McGrory-Usset M.E., and Stanton M.S. Use of implantable cardioverter defibrillator (ICD) therapy and ICD guidelines around the world. In: Ovyshcher I.E. (Ed). New development in cardiac pacing and electrophysiology (2002), Futura Publishing Company, Inc., Armonk (NY) 81-90
15. Schoenfeld M.H., Compton S.J., Mead R.H., Weiss D.N., Sherfesee L., Englund J., et al. Remote monitoring of implantable cardioverter defibrillators: a prospective analysis. Pacing Clin Electrophysiol 27 (2004) 757-763
16. Goldberg L.R., Piette J.D., Walsh M.N., Frank T.A., Jaski B.E., Smith A.L., et al. Randomized trial of a daily electronic home monitoring system in patients with advanced heart failure: The Weight Monitoring in Heart Failure (WHARF) trial. Am Heart J 146 (2003) 705-712
17. Packer M. Proposal for a new clinical end point to evaluate the efficacy of drugs and devices in the treatment of chronic heart failure. J Card Fail 7 (2001) 176-182
18. Rector T.S., and Cohn J.N. Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Pimobendan Multicenter Research Group. Am Heart J 124 (1992) 1017-1025
19. Bonow R.O., Smaha L.A., Smith Jr. S.C., Mensah G.A., and Lenfant C. The international burden of cardiovascular disease: Responding to the emerging global epidemic. Circulation 106 (2002) 1602-1605
20. HFSA 2006 comprehensive heart failure practice guideline. J Card Fail 12 (2006) e1-e122
21. Hunt S., Baker D.W., Chin M.H., Cinquegrani M.P., Feldman A., Francis G., et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the International Society for Heart and Lung Transplantation; endorsed by the Heart Failure Society of America. Circulation 104 (2001) 2996-3007
22. Heart Rhythm Society. NASPE expert consensus statement. Available from: http://hrsonline.org/swPositionStatementFiles/ps99316504.asp. Accessed April 2, 2007.